I agree with JNF. After surgery, there are often a lot of cancer cells in the bloodstream, but they are not necessarily cells capable of metastasizing. Eventually those non-viable cells die off and are filtered out. Low grade prostate cancer cells must be within prostatic tissue to survive. Only metastatic cells can survive without prostate tissue to grow in (which is what makes them lethal). If you want to know more about
this:
Can invasive procedures spread prostate cancer?I said...
Cancer cells may be released into systemic circulation by surgery. A study of circulating epithelial tumor cells in breast cancer patients found that the serum-detected cell numbers did increase in some patients following surgery, and the increase was sustained in some, indicating viability. A study of bladder cancer circulating tumor cells using CellSearch® found an increase following transurethral bladder resection. Eschwège et al. found increased numbers of prostate epithelial cells in the serum after surgery, but found no association with metastatic progression or survival. To my knowledge, there has not yet been a study specifically of circulating tumor cells pre- and post-prostatectomy.
But there may be cancerous tissue left behind that can progress to the point where it does metastasize.
I said...
Another difficulty arises where the surgeon must detach the prostate from the urethra, which runs right down the middle. The surgeon scrapes prostate tissue away from the urethra, and cuts it as far away as he can from the bladder neck on top, and the urethral sphincter, on the bottom. He then joins the two ends together, which is called an anastomosis. This procedure may leave cancerous tissue behind. In a recent CT/MRI study of post-prostatectomy tissue, 76% of recurrences after surgery were found to occur at the anastomosis. How many of those were from cancerous tissue that was left behind, and how many from contamination of the surgical blade?